Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts - PubMed (original) (raw)
. 2006 Jul 4;114(1 Suppl):I174-80.
doi: 10.1161/CIRCULATIONAHA.105.001370.
Theo Kofidis, Ian Y Chen, Georges von Degenfeld, Monika Zwierzchoniewska, Grant Hoyt, Takayasu Arai, Darren R Lebl, Stephen L Hendry, Ahmad Y Sheikh, David T Cooke, Andrew Connolly, Helen M Blau, Sanjiv S Gambhir, Robert C Robbins
Affiliations
- PMID: 16820569
- DOI: 10.1161/CIRCULATIONAHA.105.001370
Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts
Ingo Kutschka et al. Circulation. 2006.
Abstract
Background: Cell transplantation for myocardial repair is limited by early cell death. Gene therapy with human Bcl-2 (hBcl-2) has been shown to attenuate apoptosis in the experimental setting. Therefore, we studied the potential benefit of hBcl-2 transgene expression on the survival of cardiomyoblast grafts in ischemic rat hearts.
Methods and results: H9c2 rat cardiomyoblasts were genetically modified to express both firefly luciferase and green fluorescent protein (mH9c2). The cells were then transduced with adenovirus carrying hBcl-2 (AdCMVhBcl-2/mH9c2). Lewis rats underwent ligation of the left anterior descending artery (LAD) to induce a sizable left ventricular (LV) infarct. Hearts were explanted and the infarcted region was restored using collagen matrix (CM) seeded with 1x10(6) mH9c2 cells (n=9) or AdCMVhBcl-2/mH9c2 cells (n=9). Control animals received CM alone (n=6) or no infarct (n=6). Restored hearts were transplanted into the abdomen of syngeneic recipients in a "working heart" model. Cell survival was evaluated using optical bioluminescence imaging on days 1, 5, 8, 14, and 28 after surgery. The left heart function was assessed 4 weeks postoperatively using echocardiography and magnetic resonance imaging. During 4 weeks after surgery, the optical imaging signal for the AdCMVhBCL2/mH9c2 group was significantly (P<0.05) higher than that of the mH9c2-control group. Both grafts led to better fractional shortening (AdCMVhBcl-2/mH9c2: 0.21+/-0.03; mH9c2: 0.21+/-0.04; control: 0.15+/-0.03; P=0.04) and ejection fraction (AdCMVhBcl-2/mH9c2: 47.0+/-6.2; mH9c2: 48.7+/-6.1; control: 34.3+/-6.0; P=0.02) compared with controls. Importantly, no malignant cells were found in postmortem histology.
Conclusions: Transduction of mH9c2 cardiomyoblasts with AdCMVhBcl-2 increased graft survival in ischemic rat myocardium without causing malignancies. Both AdCMVhBcl-2/mH9c2 and mH9c2 grafts improved LV function.
Similar articles
- Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts.
Kutschka I, Chen IY, Kofidis T, Arai T, von Degenfeld G, Sheikh AY, Hendry SL, Pearl J, Hoyt G, Sista R, Yang PC, Blau HM, Gambhir SS, Robbins RC. Kutschka I, et al. Circulation. 2006 Jul 4;114(1 Suppl):I167-73. doi: 10.1161/CIRCULATIONAHA.105.001297. Circulation. 2006. PMID: 16820568 - In vivo optical bioluminescence imaging of collagen-supported cardiac cell grafts.
Kutschka I, Chen IY, Kofidis T, von Degenfeld G, Sheikh AY, Hendry SL, Hoyt G, Pearl J, Blau HM, Gambhir SS, Robbins RC. Kutschka I, et al. J Heart Lung Transplant. 2007 Mar;26(3):273-80. doi: 10.1016/j.healun.2006.11.604. J Heart Lung Transplant. 2007. PMID: 17346630 - Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.
Rong SL, Lu YX, Liao YH, Wang XL, Wang YJ, Chang C, Wang YQ, Liu QY, Gao YZ, Mi SH. Rong SL, et al. Chin Med J (Engl). 2008 Feb 20;121(4):347-54. Chin Med J (Engl). 2008. PMID: 18304469 - Cell therapy to repair broken hearts.
Li RK, Yau TM, Sakai T, Mickle DA, Weisel RD. Li RK, et al. Can J Cardiol. 1998 May;14(5):735-44. Can J Cardiol. 1998. PMID: 9627531 Review. - Heart grafts are becoming more common.
[No authors listed] [No authors listed] Reprod Biomed Online. 2004 Jun;8(6):681. Reprod Biomed Online. 2004. PMID: 15169585 Review. No abstract available.
Cited by
- Empowering adult stem cells for myocardial regeneration.
Mohsin S, Siddiqi S, Collins B, Sussman MA. Mohsin S, et al. Circ Res. 2011 Dec 9;109(12):1415-28. doi: 10.1161/CIRCRESAHA.111.243071. Circ Res. 2011. PMID: 22158649 Free PMC article. Review. - Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart Failure.
Rojas SV, Martens A, Zweigerdt R, Baraki H, Rathert C, Schecker N, Rojas-Hernandez S, Schwanke K, Martin U, Haverich A, Kutschka I. Rojas SV, et al. Tissue Eng Part A. 2015 Jul;21(13-14):1991-2000. doi: 10.1089/ten.TEA.2014.0537. Tissue Eng Part A. 2015. PMID: 25867819 Free PMC article. - Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts.
Don CW, Murry CE. Don CW, et al. J Cell Mol Med. 2013 Nov;17(11):1355-62. doi: 10.1111/jcmm.12147. Epub 2013 Oct 9. J Cell Mol Med. 2013. PMID: 24118766 Free PMC article. Review. - EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice.
DuSablon A, Kent S, Coburn A, Virag J. DuSablon A, et al. Cardiovasc Diabetol. 2014 Aug 13;13:114. doi: 10.1186/s12933-014-0114-y. Cardiovasc Diabetol. 2014. PMID: 25166508 Free PMC article. - Macroscopic fluorescence imaging: a novel technique to monitor retention and distribution of injected microspheres in an experimental model of ischemic heart failure.
Martens A, Rojas SV, Baraki H, Rathert C, Schecker N, Hernandez SR, Schwanke K, Zweigerdt R, Martin U, Saito S, Haverich A, Kutschka I. Martens A, et al. PLoS One. 2014 Aug 4;9(8):e101775. doi: 10.1371/journal.pone.0101775. eCollection 2014. PLoS One. 2014. PMID: 25089764 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical